Work

Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022

Year: 2023

Type: article

Abstract: We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020-December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%-46.5%). We observed no increase in the seroprevalence trend after widespread school reopening. Seroprevalence estimates complement case-based cumulative incidence.

Source: Emerging infectious diseases

DOI: 10.3201/eid2908.230471

Authors: Rebecca A. Falender, Paul G. Mitchell, Judith A. Guzman-Cottrill, Paul R. Cieslak, Melissa Sutton

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4384257645

FWCI: 0.621

Cites: 14

Cited by: 3

Related to: 10